Liisa Eisenlohr
Liisa Eisenlohr, PhD, MBA
Liisa Eisenlohr has over two decades of experience in the life sciences industry, both in global industry and consulting roles, with broad experience and knowledge spanning the areas of healthcare compliance, medical affairs, and clinical trial management.
Liisa supports clients in Europe and the United States with the establishment and review of comprehensive compliance and risk assessment programs. She has provided Independent Review Organization (IRO) services to pharmaceutical clients, conducting systems, and transaction reviews. She has also developed third-party due diligence as well as auditing and monitoring programs for life science companies of varying sizes.
Liisa advises on global Medical Affairs activities, including compliant scientific, medical, and pharmacoeconomic communications with healthcare professionals, payers, and patients; advisory board management; review of promotional and non-promotional materials (PCR/MLR); educational grant management; and publication planning, both pre-and post-product launch.
Furthermore, she provides expert consulting support for the initiation, management, and optimization of ongoing global clinical studies with medical products including drugs, biologics, and medical devices, in accordance with ICH E6 GCP and other regulatory requirements. She has a particular interest in increasing diversity and inclusion in clinical research.
Liisa is a Certified Compliance and Ethics Professional-International (CCEP-I) by the Society of Corporate Compliance and Ethics, Certified Clinical Research Associate (CCRA) by the Association of Clinical Research Professionals, and Board Certified Medical Affairs Specialists (BCMAS) by the Accreditation Council for Medical Affairs.